Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

Merit Medical Systems (MMSI), a Zacks Rank #2 (Buy) company, is well-positioned for growth driven by its broad medical device portfolio, R&D investments, and the WRAPSODY renal therapy opportunity showing strong clinical outcomes. However, the company faces headwinds from tariffs expected to reduce 2026 results by $16 million (21 cents per share) and intense competition in the medical device space.